![](/sites/default/files/styles/img_search_list_desktop/public/cp_2016_18_de.jpg?h=c99a72f4&itok=O5XBVulH)
German version - At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
German version - At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
Alexander Fleming’s discovery of Penicillin in 1928 marked one of the proudest achievements of 20th Century medicine. A decade of R&D later and suddenly mankind had the ability to fight a whole class of diseases.
Half-year 2016 results.
The interim financial report for the six months ended 30 June 2016 is available on the company's website at www.scor.com.
Billions of pounds is spent on research on cancer, and survival statistics continue to improve year on year. New treatment methods continue to be developed.
The Continuous Mortality Investigation (CMI) has recently published a new Working paper, which is in response to a key finding from Working Paper 75 which was that: “The shape of the latest [accelerated critical illne
Billions of pounds is spent on research on cancer, and survival statistics continue to improve year on year. New treatment methods continue to be developed.
Breast cancer is responsible for more than 520,000 deaths each year, and is the fifth most frequent cause of death in the world.
Breast cancer is responsible for more than 520,000 deaths each year, and is the fifth most frequent cause of death in the world.
Program of the Conference organized by the Chaire SCOR "Market Risk and Value Creation" in Paris on 10 June 2016
Around 36 million people are living with HIV in the world today. 5 million of them are also infected with the hepatitis C virus (HCV) and 4 million with hepatitis B virus (HBV).